Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21770,190,1.00 [0.87-1.14],0.9439216599355296
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22977,251,0.96 [0.86-1.08],0.5315001010993158
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22700,1746,1.02 [0.98-1.07],0.3488001883111131
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Candidiasis,22984,544,1.03 [0.95-1.11],0.4724071549252649
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22226,4203,1.04 [1.01-1.07],0.0128618639248522
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22175,4284,1.03 [1.00-1.06],0.0472511107313511
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22689,1416,1.02 [0.98-1.08],0.3254461083961827
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22885,128,1.07 [0.91-1.25],0.4263040911271828
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20180,1296,1.08 [1.03-1.14],0.0019082512766552
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19475,1580,1.03 [0.99-1.08],0.1839349014684996
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18973,340,1.01 [0.92-1.12],0.7832101740904099
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14935,2730,1.02 [0.99-1.06],0.2106045303736847
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18898,492,1.02 [0.94-1.10],0.6995427818714876
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22960,1687,1.01 [0.96-1.05],0.7819583700413428
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Mycoses,23078,638,1.06 [0.99-1.14],0.1040181999409145
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22191,1237,0.99 [0.94-1.05],0.8108015967794253
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23008,1428,1.07 [1.02-1.12],0.0041338824143393
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21524,251,0.96 [0.86-1.09],0.5455958034094888
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23138,65,1.15 [0.94-1.42],0.1796410872651275
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22830,1250,1.08 [1.03-1.14],0.002769833854375
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22840,83,0.91 [0.74-1.12],0.3676965318186823
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23074,146,1.00 [0.86-1.16],0.999739097469658
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23050,122,1.00 [0.85-1.18],0.9626305491691316
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21453,499,1.14 [1.05-1.23],0.0012167968753921
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21259,305,1.00 [0.90-1.11],0.9956542408535612
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21412,139,0.92 [0.78-1.08],0.314729200324871
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23124,52,1.02 [0.79-1.32],0.8646611442995471
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23068,173,0.99 [0.86-1.14],0.9226804396392718
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral warts,22950,55,1.08 [0.85-1.37],0.5458910369813466
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22975,80,1.05 [0.85-1.28],0.6654574309551957
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm,22845,260,1.00 [0.89-1.12],0.9669554622973208
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23055,39,0.95 [0.70-1.29],0.7313352378795306
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23039,40,1.05 [0.80-1.39],0.7148080844253557
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11010,82,0.96 [0.77-1.18],0.6737997273424596
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22665,1669,1.03 [0.99-1.08],0.1808247001161083
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of meninges,23122,65,1.08 [0.87-1.35],0.4601280985829501
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23042,80,1.09 [0.89-1.32],0.4094275934417957
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23113,121,0.91 [0.76-1.08],0.2662625181328806
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of ovary,12057,79,1.11 [0.92-1.35],0.2719842593492018
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23098,437,0.99 [0.91-1.08],0.8569679068679428
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Caecum,23103,383,1.00 [0.91-1.10],0.9722283259803144
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22988,87,0.93 [0.75-1.14],0.4620952755655797
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Descending colon,23094,253,1.05 [0.93-1.18],0.4179916622504173
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Rectum,23052,402,1.05 [0.95-1.14],0.339231802094934
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22980,680,1.00 [0.93-1.07],0.9906510298911486
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23080,540,1.04 [0.96-1.13],0.2917707261790496
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Carcinoma in situ of breast,9069,50,0.92 [0.71-1.20],0.5551087429200807
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9111,65,1.24 [1.03-1.51],0.0245735849670861
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16516,69,0.96 [0.77-1.21],0.7302147620559882
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16544,97,0.94 [0.78-1.14],0.5381230640075392
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23082,125,0.96 [0.81-1.13],0.6142125024028915
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Haemangioma, any site",23083,123,0.95 [0.80-1.13],0.5786056220738198
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Leiomyoma of uterus,11786,169,0.98 [0.85-1.13],0.7878514119994038
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Lung cancer and mesothelioma,14642,476,0.99 [0.90-1.08],0.7707172448139437
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Lymphoid leukaemia,16517,70,0.92 [0.73-1.16],0.4710881879119545
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16671,224,1.00 [0.88-1.13],0.9697267675933396
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16762,315,1.06 [0.96-1.18],0.2523270475024757
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9193,104,0.91 [0.75-1.09],0.3002533742649564
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16558,111,1.12 [0.95-1.32],0.1855679959035983
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16595,148,1.20 [1.04-1.37],0.0104706597342809
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16570,123,0.99 [0.84-1.17],0.9129481471695156
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9177,88,0.89 [0.73-1.09],0.271962946476824
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16573,126,0.91 [0.77-1.08],0.286078301404982
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8328,970,0.97 [0.92-1.03],0.379916402925823
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16577,130,0.98 [0.83-1.15],0.7871270023680084
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16538,91,1.02 [0.84-1.23],0.8570968252958985
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16594,147,1.06 [0.91-1.23],0.4342995490823261
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanocytic naevi,22992,186,1.02 [0.89-1.17],0.7612018866933474
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanocytic naevi of trunk,23110,79,1.12 [0.92-1.36],0.2553661910190939
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanoma in situ,16500,112,1.06 [0.89-1.25],0.5108097361269215
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16568,121,0.91 [0.77-1.09],0.3176585905953429
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16648,201,0.95 [0.83-1.09],0.4768889824121819
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16768,321,0.92 [0.82-1.02],0.1252464473939514
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16575,128,1.03 [0.88-1.21],0.7117411205407551
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Other benign neoplasms of skin,22962,162,0.92 [0.79-1.07],0.2936577856297477
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17930,1483,0.98 [0.94-1.03],0.4914154414276003
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18015,1568,0.98 [0.94-1.03],0.5181137258781626
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22831,393,1.03 [0.94-1.12],0.5963730443715121
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20814,165,1.13 [0.99-1.29],0.0746899263565649
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22511,73,1.13 [0.93-1.38],0.2274399106759701
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22370,3509,1.06 [1.02-1.09],0.0004292355641941
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21406,73,1.30 [1.09-1.56],0.0041552737123372
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22664,65,1.00 [0.79-1.26],0.994829750902504
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22618,1969,1.07 [1.03-1.11],0.0014612007333406
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22617,1968,1.07 [1.02-1.11],0.0017235103743167
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20764,115,0.98 [0.82-1.17],0.8530339886604741
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22772,1439,1.11 [1.06-1.16],5.374638415996716e-06
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22713,114,1.00 [0.84-1.19],0.9988200424080672
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22512,74,1.11 [0.91-1.36],0.3156040652975734
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22513,75,1.11 [0.91-1.36],0.2871417753327635
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22955,356,0.93 [0.84-1.03],0.1918448971209079
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23007,39,1.02 [0.76-1.35],0.9163765029465945
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22893,294,0.91 [0.81-1.02],0.0953672601905439
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21471,138,1.01 [0.86-1.18],0.8970754282803513
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15459,409,1.05 [0.96-1.15],0.2469027730228448
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21627,103,1.01 [0.84-1.22],0.8877266815450322
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21637,113,1.16 [0.98-1.36],0.0792735940987174
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15119,69,1.09 [0.88-1.34],0.4434663621090414
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21494,64,0.78 [0.61-1.01],0.0633208058683181
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20697,319,0.90 [0.81-1.00],0.0612700879525808
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22339,954,0.98 [0.93-1.05],0.603984831319302
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21870,485,0.98 [0.90-1.06],0.591525159859636
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21603,218,1.04 [0.92-1.18],0.5260070372132737
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22853,1423,0.99 [0.95-1.04],0.7895971087098133
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19466,1379,0.99 [0.95-1.05],0.8400155221700777
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15144,94,0.98 [0.81-1.19],0.8586262007572828
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20853,100,0.93 [0.77-1.12],0.4494817158960431
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15417,367,1.05 [0.96-1.15],0.2837572511793301
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15107,57,1.18 [0.95-1.48],0.1316274691736245
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19656,4606,0.99 [0.96-1.02],0.489409169031567
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15316,266,1.03 [0.92-1.15],0.5862462258894497
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15764,714,1.05 [0.98-1.12],0.1344126328457399
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23078,373,1.00 [0.91-1.10],0.9409900590622036
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22867,162,0.96 [0.83-1.11],0.5922575404612467
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15204,154,1.02 [0.88-1.18],0.8004431651490084
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15132,82,0.99 [0.81-1.22],0.9601025485867152
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22503,1750,1.04 [0.99-1.08],0.0898385288744752
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15438,388,1.04 [0.95-1.14],0.4309069458976344
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15478,428,1.04 [0.96-1.14],0.3281075130587924
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15914,864,1.02 [0.95-1.08],0.6211153172422224
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15226,176,0.94 [0.81-1.08],0.3901809622806007
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22857,152,0.98 [0.85-1.14],0.8005723286614558
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15947,897,1.05 [0.99-1.12],0.0803048708495987
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15709,659,0.93 [0.86-1.00],0.0429505099228641
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20458,80,0.91 [0.73-1.13],0.3851126692808527
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21493,6443,1.00 [0.98-1.03],0.7972890584878812
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20811,58,1.10 [0.88-1.37],0.4214707828404426
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20801,48,0.96 [0.73-1.25],0.7487547606018821
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22951,1909,0.98 [0.94-1.02],0.3282613239822435
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22949,1907,0.98 [0.94-1.02],0.3459118705107405
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20817,64,1.18 [0.96-1.45],0.1117807160137969
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22782,1133,0.99 [0.94-1.05],0.8381243564414449
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17286,2236,1.01 [0.97-1.05],0.6386229182447914
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23122,315,1.08 [0.98-1.20],0.1096261685809308
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21515,130,1.09 [0.93-1.27],0.2765357675000855
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21768,119,1.02 [0.86-1.20],0.824792624230369
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21815,166,1.16 [1.02-1.32],0.0256977010586872
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15251,201,1.05 [0.93-1.19],0.428543003286126
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20340,187,1.09 [0.96-1.23],0.1957816496515821
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2484,99,1.12 [0.93-1.35],0.2303715929534357
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2652,308,1.04 [0.94-1.16],0.4331368813197834
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20237,84,1.24 [1.05-1.48],0.0138898159134504
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2457,75,1.12 [0.90-1.39],0.3097524597741851
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22293,2140,0.99 [0.95-1.03],0.5896481969766167
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22019,634,0.94 [0.87-1.02],0.1273317788222314
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20832,454,0.96 [0.88-1.05],0.4126894792021333
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16167,1117,1.04 [0.99-1.10],0.1540112062885222
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23001,304,0.91 [0.82-1.02],0.1031364592732001
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21633,268,0.96 [0.85-1.08],0.5186984343246419
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Angina pectoris,19974,1568,0.96 [0.92-1.01],0.0924800091577029
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21737,372,0.95 [0.86-1.05],0.3253290975821402
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21453,88,1.13 [0.94-1.36],0.1968329414891804
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21661,296,1.11 [1.00-1.23],0.0523297849016861
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11718,2850,0.97 [0.93-1.00],0.0528084347873993
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,AV-block,17560,678,1.03 [0.96-1.11],0.3778224966984218
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23052,580,0.96 [0.88-1.03],0.267556297769887
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cardiac arrest,9131,263,1.08 [0.97-1.20],0.1825788329829695
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17089,207,0.80 [0.69-0.92],0.0017472221010555
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16994,112,0.84 [0.69-1.01],0.0685004580596029
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23132,81,1.00 [0.81-1.23],0.9833045187887036
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Conduction disorders,18447,1565,1.01 [0.97-1.06],0.6148600153925523
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21143,2762,0.98 [0.94-1.01],0.1980006500444301
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18576,8908,1.01 [0.99-1.03],0.5896072490436151
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21553,335,0.91 [0.82-1.01],0.0861273272954834
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Endocarditis,16984,102,1.25 [1.07-1.46],0.0058437518374348
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22849,1667,1.00 [0.96-1.05],0.9821140700027544
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypertension,19818,7925,1.00 [0.98-1.03],0.648379350113663
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19836,7943,1.00 [0.98-1.02],0.7023082582861722
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22963,99,1.03 [0.86-1.24],0.7469310362218483
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12154,261,1.04 [0.93-1.16],0.4937935167980716
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12100,207,1.03 [0.91-1.17],0.6216468696211538
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypotension,22951,1652,1.01 [0.97-1.06],0.5387486170576891
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21844,149,0.98 [0.84-1.14],0.8214224267061851
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21316,2910,0.98 [0.94-1.01],0.1756986986955441
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22622,801,1.03 [0.97-1.10],0.327302361532799
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17406,524,1.01 [0.93-1.10],0.8039171498157401
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22448,1063,1.00 [0.95-1.06],0.9824318102221148
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19322,916,1.00 [0.95-1.07],0.8894956046972913
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23007,190,1.18 [1.04-1.33],0.00911859861425
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23094,409,0.98 [0.89-1.07],0.6370255377643468
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Oesophageal varices,21286,68,1.04 [0.83-1.29],0.7491576733975669
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other aneurysm,21471,106,1.01 [0.85-1.21],0.8904494382374226
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other arrhythmias,17482,600,1.03 [0.95-1.11],0.5031239436971549
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21502,137,1.09 [0.94-1.27],0.2655573109255603
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21699,334,0.97 [0.87-1.08],0.5644421890400545
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17103,221,0.97 [0.85-1.10],0.6251854770071176
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other disorders of veins,21339,121,1.09 [0.93-1.28],0.286418798991911
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21266,48,0.91 [0.69-1.20],0.494780054183375
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21077,90,0.93 [0.76-1.14],0.4743957936592798
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21398,180,1.01 [0.88-1.16],0.850166814043904
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18354,1472,1.00 [0.95-1.05],0.9991021232494371
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21361,62,0.90 [0.70-1.15],0.4060834987342432
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22096,731,1.04 [0.97-1.11],0.3178684830796242
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22369,528,1.00 [0.92-1.08],0.9903002435497092
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21965,978,1.00 [0.95-1.06],0.922960946535224
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9282,414,0.92 [0.84-1.02],0.1064159194728585
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21927,597,1.03 [0.96-1.11],0.4108115819653175
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21641,423,0.94 [0.86-1.04],0.2219779571120862
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22437,596,1.00 [0.93-1.08],0.979181633994322
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23038,973,1.02 [0.96-1.08],0.4990180684900213
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17401,519,1.02 [0.95-1.11],0.5521531933866127
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22364,523,1.00 [0.93-1.09],0.9355364465211192
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21254,267,1.01 [0.91-1.14],0.8147675507426503
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22607,912,1.02 [0.96-1.09],0.4475067599697986
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22592,953,1.03 [0.97-1.09],0.3366243795516323
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21810,63,1.09 [0.88-1.36],0.4275842423194574
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21471,106,0.85 [0.70-1.03],0.099861786895381
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22146,325,1.04 [0.94-1.15],0.418416150859904
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21717,332,1.00 [0.91-1.11],0.9522147519297488
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Varicose veins,21740,522,1.00 [0.92-1.08],0.952717102753267
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21387,121,0.99 [0.84-1.17],0.91429828346415
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22860,942,0.99 [0.93-1.05],0.6528708897471796
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23054,334,1.10 [1.00-1.21],0.0556553772498622
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19764,1381,1.01 [0.96-1.06],0.830300265931766
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Any mental disorder,22603,4220,1.00 [0.97-1.03],0.9911245431472704
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23025,392,1.06 [0.97-1.17],0.1994851253293653
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19834,1451,0.99 [0.94-1.04],0.5940463084049502
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18470,87,1.09 [0.91-1.32],0.3456075989428027
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Smoking dependency,22623,1182,0.97 [0.91-1.03],0.2695274655286869
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19836,1453,0.99 [0.94-1.04],0.7390823125048699
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Vascular dementia,22232,228,0.94 [0.83-1.07],0.3443046990724575
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Alzheimer disease,23134,595,1.03 [0.95-1.11],0.4823382037916466
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14166,111,0.99 [0.83-1.18],0.9007285374532352
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Bell's palsy,21277,86,1.15 [0.96-1.38],0.1182254250145679
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21685,494,1.02 [0.94-1.11],0.582235666779194
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Cerebral cysts,22683,250,1.05 [0.94-1.18],0.4141569432646508
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23061,412,1.00 [0.91-1.10],0.972177209523299
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22283,76,1.02 [0.83-1.26],0.8626065040326484
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23118,69,0.81 [0.64-1.04],0.1034327683128078
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22520,87,1.14 [0.95-1.37],0.1720168031179578
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Epilepsy,21619,304,0.97 [0.88-1.09],0.6381622178524188
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22670,1355,1.00 [0.95-1.05],0.9284566187355336
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23080,920,1.00 [0.94-1.06],0.9007922204139046
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22474,3461,1.00 [0.97-1.04],0.8445722785103006
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Generalized epilepsy,22750,52,1.18 [0.94-1.49],0.1536035038440777
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Hemiplegia,22988,339,1.02 [0.92-1.13],0.6858097149972959
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Hydrocephalus,22507,74,0.99 [0.80-1.22],0.9102998647916448
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23121,73,1.04 [0.85-1.28],0.7043605275502711
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21258,67,0.82 [0.64-1.04],0.1071779414111108
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21265,74,0.94 [0.76-1.18],0.6059448905055831
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Memory loss,21983,142,1.02 [0.87-1.19],0.8148877809794782
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Migraine,21598,283,1.00 [0.90-1.11],0.9917429440824156
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23087,259,1.01 [0.90-1.13],0.859140120284309
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Motor neuron disease,14253,174,1.08 [0.95-1.24],0.253925587269605
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23003,61,1.06 [0.84-1.34],0.6060585020606952
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22424,1233,1.01 [0.96-1.06],0.7094305150414039
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Neurological diseases,21646,4370,1.01 [0.98-1.04],0.5856693556901329
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22527,320,0.96 [0.86-1.06],0.4221590078212296
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21618,427,1.00 [0.92-1.10],0.9283871235582564
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23058,350,1.09 [0.99-1.19],0.0836369499508839
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17294,978,1.01 [0.96-1.08],0.6195674760579515
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22520,87,1.01 [0.83-1.23],0.905323190301344
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22594,161,0.93 [0.80-1.08],0.3436860679228737
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22392,232,0.96 [0.85-1.09],0.5223652525640536
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21288,97,1.11 [0.94-1.32],0.2300186720162541
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other headache syndromes,21368,53,0.85 [0.65-1.11],0.2395004577740184
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other neurological diseases,23020,587,1.03 [0.96-1.11],0.4159363662432048
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other sleep disorders,21832,517,1.00 [0.92-1.09],0.9868394798054144
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Parkinson's disease,23101,683,0.99 [0.92-1.06],0.7294805318023709
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22480,47,1.03 [0.79-1.34],0.8407588005991418
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Restless leg syndrome,23135,104,0.97 [0.81-1.16],0.7272569858170316
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Sleep apnoea,22905,439,1.01 [0.92-1.11],0.8041434641985978
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22770,62,1.10 [0.88-1.37],0.3892324881247972
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23123,202,1.03 [0.91-1.18],0.6033382794005409
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21261,70,0.95 [0.76-1.19],0.6507325103298275
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23134,601,1.02 [0.95-1.10],0.5547860278599815
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22170,222,0.94 [0.83-1.07],0.3780679678722679
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22486,157,1.04 [0.90-1.20],0.608787859192512
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22675,564,0.97 [0.89-1.04],0.388483606988522
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22882,266,1.01 [0.90-1.13],0.8865997179092001
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21905,69,0.96 [0.76-1.20],0.6974028583421912
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21873,37,1.02 [0.75-1.38],0.8994683923250418
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23012,75,1.04 [0.85-1.28],0.6976332287780049
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22817,226,0.98 [0.87-1.11],0.7968939876427199
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2462,77,1.08 [0.87-1.34],0.4872924174243584
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3030,112,1.09 [0.91-1.30],0.3562063977769623
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22439,110,1.10 [0.93-1.30],0.2610592215613077
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22834,1421,1.01 [0.97-1.06],0.5982244999924068
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22721,885,0.96 [0.90-1.02],0.206195411833087
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22139,303,1.03 [0.93-1.15],0.5157619759559974
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23060,949,0.97 [0.92-1.03],0.3731497421517944
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23128,80,1.08 [0.88-1.31],0.464535437118078
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22988,877,0.98 [0.92-1.04],0.4496267677074423
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23091,500,1.02 [0.94-1.10],0.6825228306865161
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23014,229,0.92 [0.81-1.04],0.1794770594565211
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21938,102,1.00 [0.83-1.20],0.9969611747341672
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21942,106,1.04 [0.87-1.24],0.691334411709552
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21913,77,0.98 [0.79-1.21],0.8192066927409207
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22998,1014,0.97 [0.92-1.03],0.3864749368819266
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22252,268,1.03 [0.92-1.15],0.5951848957075747
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22183,72,0.87 [0.69-1.09],0.2253310689444345
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22716,125,1.03 [0.87-1.21],0.7499232209231201
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22980,389,0.99 [0.91-1.09],0.8894056085375944
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22334,223,1.02 [0.90-1.15],0.7585935659289742
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22930,145,0.87 [0.74-1.02],0.0912624421592954
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22663,679,0.99 [0.92-1.06],0.6993657399251598
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22488,159,0.88 [0.75-1.02],0.0975557434068219
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20661,3233,0.99 [0.96-1.02],0.57671365417973
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22936,345,0.98 [0.88-1.08],0.6240207935481547
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23120,188,1.06 [0.93-1.21],0.3597118589975391
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22380,544,0.97 [0.89-1.05],0.4066308011429279
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22682,91,0.98 [0.80-1.19],0.8204072322033917
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23120,72,1.02 [0.82-1.27],0.8548994389365362
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21964,128,0.76 [0.63-0.91],0.0031540720320308
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22008,172,0.94 [0.82-1.09],0.4425357369781106
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21577,164,1.02 [0.88-1.17],0.8353627526649454
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22174,63,0.74 [0.57-0.97],0.0265793398537362
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21487,74,0.90 [0.72-1.13],0.3550331971307913
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22096,112,0.78 [0.64-0.94],0.0096269365919504
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22280,296,0.97 [0.87-1.08],0.559830677918085
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21997,161,0.91 [0.78-1.06],0.2406247868924282
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21508,95,1.12 [0.94-1.34],0.211778029311587
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21545,132,0.96 [0.82-1.13],0.6493392824761599
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20180,2752,1.00 [0.96-1.03],0.925724310165013
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21929,93,1.19 [1.01-1.41],0.0418731968075309
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22841,512,0.98 [0.90-1.06],0.59310102294885
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22410,81,0.91 [0.73-1.12],0.3772197589451319
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22537,208,1.00 [0.88-1.14],0.965862726499506
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22914,113,0.98 [0.82-1.17],0.8071266865124485
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23088,140,1.03 [0.88-1.20],0.7143663631732668
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22996,118,1.15 [0.98-1.34],0.0830475893600069
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22865,64,0.92 [0.72-1.16],0.4706227305083369
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22871,70,1.15 [0.94-1.41],0.1605874141883298
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23028,1243,0.99 [0.94-1.05],0.8279959864837083
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22727,942,1.02 [0.96-1.09],0.4360831808244542
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21941,156,0.90 [0.77-1.05],0.1646170500348225
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21873,88,1.00 [0.82-1.21],0.988591211280728
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute pharyngitis,22943,66,0.97 [0.77-1.23],0.8298381269753019
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23062,185,0.93 [0.81-1.07],0.295694279075969
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22938,61,0.98 [0.77-1.25],0.884313046859639
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,All influenza,20452,158,1.07 [0.93-1.24],0.3334429696667967
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20449,155,1.08 [0.93-1.24],0.3079185359244629
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14270,104,1.21 [1.03-1.42],0.0227499044681931
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Allergic rhinitis,23025,234,1.05 [0.94-1.18],0.3859072418445941
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15481,1707,1.05 [1.01-1.10],0.0192322642849742
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15850,1684,1.05 [1.00-1.10],0.0318142593499047
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22620,180,1.03 [0.90-1.18],0.6714222776021435
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20398,104,0.89 [0.73-1.08],0.2536762586625484
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Bronchiectasis,19397,518,1.07 [0.99-1.15],0.1051758447192954
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18950,71,1.02 [0.82-1.26],0.8777194816346834
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22003,3124,1.06 [1.02-1.09],0.0006101396887924
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21911,71,1.11 [0.90-1.36],0.3160063233670953
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Chronic sinusitis,21974,134,0.95 [0.81-1.12],0.5512194569740367
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22845,1639,1.02 [0.98-1.07],0.3106540821198602
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Deviated nasal septum,21922,82,1.01 [0.82-1.23],0.9612252552989158
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20980,6094,1.04 [1.02-1.07],0.0002580506933964
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22180,340,0.99 [0.90-1.10],0.9071384004779298
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Early onset COPD,21314,108,0.95 [0.79-1.14],0.5903959572990476
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Emphysema,19313,434,1.05 [0.96-1.15],0.2772485438152399
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21828,451,1.13 [1.04-1.23],0.0028843437803966
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22879,2585,1.05 [1.01-1.08],0.0127609289224663
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Interstitial lung disease,21871,494,1.14 [1.06-1.23],0.0007601210462503
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Later onset COPD,22616,1531,1.03 [0.98-1.08],0.2320988768000685
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23119,498,1.05 [0.97-1.14],0.269549985710494
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Nasal polyp,21937,97,0.94 [0.78-1.15],0.5666083661825706
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22848,1294,1.01 [0.96-1.07],0.591456905058509
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other diseases of pleura,22845,2679,1.05 [1.02-1.09],0.0033518503225834
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22590,750,1.02 [0.95-1.09],0.5673196790831082
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other pleural conditions,20234,68,1.07 [0.86-1.33],0.534057769545293
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23014,591,1.12 [1.05-1.21],0.0014339995833447
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23006,1705,1.06 [1.01-1.11],0.0104634583508611
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pleural effusion,21537,1371,1.03 [0.98-1.09],0.175888795768649
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pleural plaque,20421,255,1.04 [0.93-1.17],0.4615851604890061
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22592,2298,1.05 [1.01-1.09],0.0167471322917475
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23008,387,1.04 [0.94-1.14],0.4649478173656693
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pneumothorax,20334,168,0.90 [0.78-1.05],0.1871722277359832
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pollen allergy,23123,199,1.05 [0.93-1.19],0.4185456625202729
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pulmonary oedema,22517,94,1.03 [0.86-1.24],0.7475841567768369
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14237,71,0.96 [0.76-1.22],0.756203025025969
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22824,1270,1.01 [0.96-1.07],0.630007766321321
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22076,236,1.05 [0.94-1.18],0.3992496212504098
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Viral pneumonia,20595,301,1.00 [0.90-1.11],0.9992452630168686
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22628,239,0.98 [0.87-1.11],0.7272217999991885
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7375,121,0.91 [0.76-1.08],0.2880431639535016
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14647,60,1.13 [0.90-1.42],0.276449419607221
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute appendicitis,23019,124,1.04 [0.88-1.22],0.6338676883450163
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute gastritis,16063,104,1.16 [0.98-1.37],0.0766153332723801
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute pancreatitis,21089,195,1.15 [1.02-1.30],0.0225542513058271
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute peritonitis,22644,113,1.09 [0.93-1.29],0.2859971187198263
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22154,65,1.32 [1.09-1.61],0.005331480425928
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Barrett oesophagus,16460,501,1.05 [0.97-1.14],0.237064917219705
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21038,144,1.08 [0.93-1.26],0.3013916747223072
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22712,144,1.08 [0.93-1.25],0.3206204056980731
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Cholecystitis,21117,223,0.96 [0.85-1.09],0.5274354819822888
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Cholelithiasis,21950,1056,1.08 [1.02-1.14],0.0077238553938664
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Chronic gastritis,16302,343,1.02 [0.92-1.12],0.7203605581049985
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20948,54,1.21 [0.97-1.51],0.0983752337407608
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22993,129,1.05 [0.89-1.23],0.5887372912283833
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Coeliac disease,21391,127,1.23 [1.07-1.42],0.0035133819893624
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Collagenous colitis,21380,99,0.91 [0.75-1.11],0.3584892085723494
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23018,158,0.97 [0.83-1.12],0.6461770888006296
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Constipation,22849,2126,1.01 [0.98-1.06],0.4720465920160404
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Crohn disease,21371,90,1.13 [0.94-1.35],0.1922415953930684
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22783,69,1.04 [0.84-1.30],0.6972853010219007
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21363,82,1.14 [0.95-1.38],0.1589435242343496
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Dental caries,22520,191,0.99 [0.87-1.14],0.9296576944880556
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19977,2563,1.05 [1.01-1.09],0.0087297303500024
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of appendix,23050,155,0.97 [0.83-1.12],0.6564989275224831
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of liver,23016,927,1.03 [0.97-1.09],0.3313048326075249
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20563,4604,1.02 [0.99-1.05],0.1228806343804628
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22805,476,0.97 [0.89-1.06],0.5324446346692848
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23042,511,1.04 [0.96-1.12],0.3726184494658616
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22423,94,0.88 [0.72-1.08],0.2159913925169366
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22293,60,1.10 [0.88-1.38],0.4141436742551486
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22797,1533,1.02 [0.97-1.07],0.3877209645485094
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of tongue,22312,97,1.05 [0.88-1.26],0.5781293624100254
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22414,1520,1.07 [1.02-1.12],0.0031006943014829
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18365,3778,1.00 [0.97-1.03],0.8098587071822654
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Duodenal ulcer,16209,250,0.97 [0.86-1.09],0.5987186116051617
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23039,204,0.97 [0.85-1.11],0.6695926585336658
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23096,26,1.19 [0.86-1.64],0.289250944041489
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22240,151,1.05 [0.91-1.22],0.5050550875798403
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14694,107,0.90 [0.75-1.09],0.2725799747089705
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Functional dyspepsia,16522,563,0.98 [0.90-1.06],0.5579041595593943
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastric ulcer,16389,430,1.06 [0.97-1.15],0.1985460024546927
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18635,2676,1.00 [0.96-1.03],0.8240151310033709
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16614,655,1.04 [0.97-1.11],0.3014150579211662
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16684,8220,1.02 [1.00-1.04],0.0613021983315041
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,GI-bleeding,22540,1276,1.00 [0.95-1.05],0.9475965282604506
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22375,46,0.75 [0.56-1.02],0.0685002557064787
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15573,1173,0.98 [0.93-1.03],0.4498663756623753
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22160,71,1.08 [0.88-1.34],0.4653267781576804
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Hernia,21066,3652,1.03 [1.00-1.06],0.0322035841554428
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Impacted teeth,23100,24,1.29 [0.94-1.76],0.1103256642260867
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Impaction of intestines,14664,77,0.95 [0.76-1.18],0.6321167317542922
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Inguinal hernia,18513,1099,1.02 [0.97-1.08],0.4540210130803507
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17537,123,0.86 [0.72-1.03],0.0966235907651867
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14703,116,1.26 [1.09-1.45],0.0021321216039026
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21410,146,1.14 [0.99-1.31],0.0760574635234382
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15102,515,1.02 [0.94-1.11],0.5822767843405292
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23103,339,1.09 [0.99-1.20],0.0751761686472505
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22069,788,1.05 [0.99-1.12],0.1108830258038402
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22372,1091,1.04 [0.98-1.10],0.1872972307611758
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16180,221,1.03 [0.91-1.17],0.594495165167717
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oesophagitis,16658,699,1.05 [0.98-1.12],0.1829629715973783
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23082,136,1.15 [1.00-1.33],0.0566835573690541
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17497,83,1.10 [0.91-1.34],0.3106315111157703
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15959,1372,0.98 [0.94-1.04],0.5582268187462031
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21254,360,1.09 [0.99-1.19],0.0766065266117774
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21042,148,1.06 [0.92-1.23],0.4265834170038846
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of intestine,16531,1944,0.98 [0.94-1.03],0.4130004661470887
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of intestines,20803,6216,1.00 [0.97-1.02],0.8482384285983696
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22276,212,1.09 [0.96-1.23],0.1711820798183185
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of liver,22854,765,1.01 [0.94-1.08],0.7996524666835936
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16722,763,1.04 [0.97-1.11],0.2815650337389628
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21106,212,0.96 [0.84-1.09],0.4936861252501652
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22962,431,1.02 [0.93-1.11],0.7214264481897887
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17051,1092,1.03 [0.98-1.09],0.2315578372564624
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22557,1293,1.00 [0.95-1.06],0.904723808001549
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22509,180,0.96 [0.83-1.10],0.5234606860969417
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16759,2172,1.01 [0.98-1.06],0.4797979768876375
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18146,2187,1.03 [1.00-1.08],0.0812053470444991
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22205,116,1.09 [0.93-1.29],0.2799671274855294
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22241,960,1.03 [0.97-1.09],0.2864031008428123
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15038,451,0.98 [0.89-1.07],0.5774505331497827
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23092,30,1.22 [0.91-1.63],0.19003750969148
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15208,621,1.01 [0.94-1.09],0.7559891428733017
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21418,154,1.02 [0.88-1.19],0.7550978481207024
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23123,53,0.94 [0.73-1.22],0.6600108276043777
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22323,103,1.06 [0.89-1.26],0.5077024555680348
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Toxic colitis,21361,80,0.94 [0.76-1.16],0.56668394718728
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16300,341,1.08 [0.98-1.19],0.1316521146394477
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ulcerative colitis,21449,168,1.15 [1.01-1.31],0.0392545989892634
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21414,133,1.20 [1.04-1.38],0.0117931030583905
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Umbilical hernia,17667,253,0.93 [0.83-1.05],0.2621727519263874
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14833,246,1.01 [0.89-1.13],0.913812192227806
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ventral hernia,17706,292,1.00 [0.89-1.11],0.9527207934331416
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Volvulus,14682,95,0.88 [0.72-1.08],0.2248797960455044
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23029,429,0.97 [0.88-1.06],0.4732329209131716
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22777,65,1.00 [0.80-1.26],0.9948038826765764
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20581,170,0.91 [0.78-1.05],0.1920386226183781
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22500,834,1.05 [0.99-1.12],0.1285648563098289
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21809,143,0.98 [0.84-1.14],0.7832564881480443
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21041,630,1.02 [0.95-1.10],0.588786743715292
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22793,318,1.12 [1.01-1.23],0.0273512307305742
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23033,558,1.07 [1.00-1.16],0.0668147592032694
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22520,45,1.09 [0.84-1.41],0.5318181361895938
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21530,3727,1.01 [0.98-1.04],0.4026838765945435
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22698,435,0.95 [0.87-1.04],0.2473541631364886
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22567,304,0.92 [0.83-1.03],0.1584507542668928
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22750,1084,1.01 [0.96-1.07],0.6215508230279914
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23115,59,1.02 [0.80-1.29],0.8971422639159083
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20468,57,1.00 [0.79-1.27],0.989526920162482
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22323,60,0.99 [0.77-1.26],0.9156901357237728
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22780,305,1.11 [1.00-1.22],0.0487175568970933
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21015,604,0.96 [0.89-1.04],0.3396715992492904
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20502,91,0.89 [0.72-1.09],0.2645346020765963
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23046,95,0.99 [0.82-1.20],0.9307534750339368
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21906,240,1.09 [0.98-1.23],0.122160745987731
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22933,221,0.91 [0.80-1.04],0.1510592576282036
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22571,96,0.98 [0.81-1.19],0.8408638050153694
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20490,79,1.01 [0.83-1.24],0.8922675725650839
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22522,2111,1.02 [0.98-1.06],0.4558107110386014
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21060,649,0.96 [0.89-1.03],0.2662737548721138
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20506,95,0.92 [0.75-1.12],0.3938054134980204
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23043,331,0.97 [0.87-1.08],0.5571471045017566
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22551,76,1.11 [0.91-1.35],0.3129340792837503
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22983,271,0.94 [0.84-1.06],0.3339971736623752
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23062,462,0.95 [0.87-1.04],0.2395013432288008
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20538,127,0.90 [0.76-1.07],0.2329458666488525
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20749,338,0.92 [0.83-1.02],0.1155802078731659
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23050,450,0.95 [0.87-1.04],0.2468880329081085
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20749,338,1.11 [1.00-1.22],0.0395226101697201
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23108,157,1.03 [0.89-1.19],0.6925516032640667
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19285,82,1.12 [0.93-1.35],0.2369546451848717
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20383,6457,1.02 [0.99-1.04],0.1351695438628752
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18971,5045,1.03 [1.01-1.06],0.0189447641285048
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19257,54,0.89 [0.69-1.16],0.4040365197420716
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19184,146,0.92 [0.78-1.08],0.2939062416752366
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19232,194,0.91 [0.80-1.05],0.2019732548499232
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22870,66,0.97 [0.78-1.22],0.8086071289785028
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19191,153,0.96 [0.82-1.11],0.568486044185375
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15411,1485,1.04 [1.00-1.09],0.0746183568534307
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22927,241,1.04 [0.93-1.17],0.5116952202232917
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19631,593,1.00 [0.93-1.07],0.946773256536748
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18717,8052,1.02 [1.00-1.04],0.0779424557670779
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20577,123,0.98 [0.83-1.16],0.7942818054713117
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19387,184,1.02 [0.90-1.17],0.7464937589506386
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19708,505,1.01 [0.93-1.09],0.8333840838538922
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22201,3163,0.98 [0.95-1.01],0.2634097818138353
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19515,312,0.92 [0.82-1.03],0.137174514003548
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19351,148,1.09 [0.95-1.25],0.2244985091109201
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19316,113,1.03 [0.87-1.22],0.7322955333773026
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22379,101,1.02 [0.85-1.22],0.8515180432877846
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15941,2015,1.02 [0.98-1.06],0.2859748926764349
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14721,795,1.09 [1.02-1.16],0.007891918464097
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23037,788,1.09 [1.02-1.16],0.0094398669890861
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14002,76,1.05 [0.86-1.29],0.6355764627879441
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14229,303,0.99 [0.89-1.10],0.8617156072980973
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19470,267,0.95 [0.85-1.07],0.3876449424289201
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14406,480,0.93 [0.85-1.01],0.0972269295819435
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19120,82,1.23 [1.03-1.47],0.0207133107425615
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19727,689,0.95 [0.89-1.03],0.2043219567492546
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19354,316,1.03 [0.93-1.14],0.5298642220864566
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14374,448,0.94 [0.86-1.02],0.1545218460273127
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19272,69,1.03 [0.83-1.28],0.7922486884567636
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19263,60,1.10 [0.88-1.37],0.4070501624291816
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20539,85,1.07 [0.88-1.30],0.4948654501768434
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22698,2244,0.99 [0.96-1.03],0.7824138871911405
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22030,1576,0.98 [0.94-1.03],0.4342394548094931
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22960,544,1.04 [0.97-1.13],0.2632448849485627
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17084,3158,1.03 [1.00-1.06],0.0622996745778978
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13969,43,0.89 [0.66-1.20],0.4501181859466425
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19309,106,0.98 [0.82-1.17],0.8416578836145561
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13997,71,1.03 [0.83-1.28],0.7700416714377416
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14061,135,0.97 [0.83-1.14],0.6941923113049427
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20700,246,0.93 [0.83-1.05],0.264997462709188
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20963,509,1.05 [0.97-1.14],0.2065930418051118
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23111,113,1.15 [0.98-1.35],0.0786434004038285
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21031,1993,0.98 [0.94-1.02],0.3545461301091566
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19279,76,1.07 [0.87-1.31],0.5180127607270137
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14080,154,1.06 [0.92-1.22],0.4576511466170593
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19833,795,1.02 [0.96-1.09],0.4553964236529756
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16120,2194,0.99 [0.95-1.03],0.6683706712039905
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22406,128,1.02 [0.87-1.20],0.8056468436914547
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23123,62,1.01 [0.80-1.28],0.9241085625582188
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19282,79,0.98 [0.80-1.21],0.8755756110373047
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20556,1353,1.03 [0.98-1.08],0.2653733699416638
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19312,109,1.07 [0.91-1.27],0.4134108064423026
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15992,2066,1.03 [0.99-1.07],0.1770658144492723
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20572,118,0.85 [0.70-1.02],0.0729485653807924
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19240,37,0.99 [0.74-1.35],0.9736813759696124
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19237,199,0.90 [0.79-1.04],0.1469341868800437
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19893,690,0.98 [0.92-1.05],0.6267493424976294
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22770,492,1.15 [1.07-1.24],0.0002182040171513
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19698,660,1.00 [0.93-1.07],0.9995440802240386
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22975,538,1.05 [0.97-1.13],0.2569271897077877
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23109,70,1.24 [1.03-1.50],0.0263561831522191
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19370,167,0.90 [0.78-1.05],0.1704544950198119
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17989,897,0.99 [0.93-1.05],0.7209873524656301
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19845,642,1.06 [0.99-1.13],0.1235898992304257
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19483,280,0.93 [0.83-1.05],0.232845348865138
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13997,71,1.07 [0.87-1.32],0.5109324335328029
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17047,3121,1.04 [1.00-1.07],0.030157043513509
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14770,844,1.06 [1.00-1.13],0.0517174623343606
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22652,374,1.10 [1.00-1.20],0.0470104147468781
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23078,80,1.04 [0.86-1.28],0.6661208325839512
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20470,72,1.03 [0.84-1.27],0.7586670853645678
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13989,63,1.01 [0.80-1.27],0.9178132673808764
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19144,106,1.12 [0.95-1.32],0.1880645005949147
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14477,551,1.05 [0.98-1.14],0.1759674832921121
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19542,339,1.00 [0.90-1.10],0.9415325237907156
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19326,288,1.00 [0.90-1.12],0.9356480168318618
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19307,269,0.98 [0.88-1.10],0.7294637178129922
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16252,68,1.18 [0.97-1.44],0.101456611398099
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23113,74,1.17 [0.97-1.42],0.1062470871617469
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19760,557,1.00 [0.93-1.08],0.9944058567217918
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22373,95,1.19 [1.01-1.41],0.0343104910055899
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21845,2642,1.02 [0.98-1.06],0.2982870808594553
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19350,147,0.99 [0.85-1.15],0.8626952525972743
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19763,725,0.98 [0.91-1.05],0.4850468361119848
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21759,278,0.90 [0.80-1.01],0.0694975664364361
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19299,261,0.93 [0.83-1.04],0.2139590598856484
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21058,2020,0.98 [0.94-1.02],0.2461284422824754
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20349,1311,1.00 [0.95-1.05],0.9803540432602312
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19266,63,0.97 [0.77-1.22],0.7868025710501305
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22397,119,1.16 [1.00-1.35],0.0575590926641647
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19366,163,1.06 [0.92-1.22],0.427519265114517
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19292,89,0.91 [0.75-1.12],0.3750013457060289
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14002,76,1.15 [0.95-1.39],0.1470871048669391
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21610,2248,1.06 [1.02-1.10],0.002431665922332
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9276,26,0.99 [0.69-1.41],0.94033054321236
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11757,33,1.06 [0.78-1.43],0.7292703446914914
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22806,308,1.09 [0.99-1.21],0.0876757503865613
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22599,101,1.01 [0.84-1.22],0.9270657380119338
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21710,2348,1.03 [0.99-1.07],0.1073866867502192
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22900,133,1.20 [1.04-1.38],0.0128651748021021
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22825,416,1.02 [0.93-1.12],0.6302167342080469
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Cystitis,19272,300,1.05 [0.94-1.16],0.4021583104630092
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Dialysis,19460,98,1.13 [0.95-1.34],0.1728685570331198
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10180,2135,0.98 [0.94-1.02],0.3096827823254318
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11860,136,1.04 [0.90-1.21],0.5691106167056658
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Endometriosis,9290,40,0.98 [0.74-1.31],0.9101486183562468
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9834,584,1.03 [0.96-1.11],0.4455743456864208
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19048,6288,1.00 [0.98-1.03],0.9000312635338168
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22865,98,1.20 [1.01-1.42],0.0347619922616207
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Hydrocele,8161,116,0.94 [0.79-1.13],0.5126740631413265
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19428,349,1.02 [0.92-1.13],0.6846882603063584
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9870,1825,0.98 [0.94-1.02],0.3208317317008115
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11931,158,1.00 [0.87-1.16],0.9568967455745212
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8169,124,0.80 [0.66-0.96],0.0152539147611134
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19058,86,0.94 [0.77-1.15],0.5577556203259848
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10282,1032,0.98 [0.93-1.04],0.5296586024219112
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8105,60,0.97 [0.76-1.23],0.7786919010037023
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9289,39,1.17 [0.90-1.52],0.2359487924234362
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23120,87,1.07 [0.88-1.29],0.4916012787203814
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23122,86,1.01 [0.83-1.23],0.907997628835066
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21925,2953,1.01 [0.98-1.05],0.5140275781456448
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19915,943,0.99 [0.93-1.05],0.6455566305752186
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11776,52,0.93 [0.72-1.21],0.6042274616817012
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23046,637,1.03 [0.96-1.11],0.4175276604961723
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8196,151,0.98 [0.84-1.14],0.7529979316185138
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8204,159,0.96 [0.82-1.11],0.5674258040074383
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8196,151,1.05 [0.90-1.21],0.5441533609852159
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23095,87,1.05 [0.86-1.27],0.6425113819119701
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21318,2346,1.02 [0.98-1.06],0.2631185183426135
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11855,82,1.05 [0.86-1.27],0.6294805776766736
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9319,69,0.92 [0.73-1.15],0.4608215174117387
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9387,137,0.87 [0.74-1.03],0.1089384552195896
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9302,52,0.89 [0.68-1.16],0.3942661777737961
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9353,103,1.02 [0.85-1.21],0.8659031409458763
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19492,413,1.01 [0.92-1.11],0.8481163198241309
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22611,202,1.04 [0.91-1.18],0.5792533651026338
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9375,125,1.11 [0.96-1.29],0.1706456631925739
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9275,25,0.92 [0.63-1.35],0.680753395819695
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9460,210,0.94 [0.83-1.07],0.3656466740359795
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9343,93,1.08 [0.90-1.29],0.4304452099611653
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9459,209,0.95 [0.83-1.08],0.4217434939064465
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22815,48,0.89 [0.68-1.18],0.4351356504951675
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8200,155,0.96 [0.82-1.12],0.6132239238085164
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22843,3764,1.03 [1.00-1.06],0.0424906701836172
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19173,94,1.05 [0.88-1.27],0.5755840644697154
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19542,180,0.90 [0.78-1.04],0.1525358744070791
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22538,40,0.80 [0.58-1.11],0.1754376720286475
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19241,269,1.08 [0.97-1.20],0.1643428566450662
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22892,394,1.04 [0.95-1.14],0.3638269865946721
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9287,37,0.90 [0.66-1.23],0.5035851488534782
